Title
Observed High Adherence to Recombinant Human Growth Hormone Treatment Using a Multi-Component Approach to Improve Adherence in Individuals with Growth Disorders
Author
Morgan, K.
van Dommelen, P.
Batista, A.R.
Koledova, E.
Contributor
Séroussi, B. (editor)
Weber, P. (editor)
Dhombres, F. (editor)
Grouin, C. (editor)
Liebe, J.D. (editor)
Pelayo, S. (editor)
Pinna, A. (editor)
Rance, B. (editor)
Sacchi, L. (editor)
Ugon, A. (editor)
Benis, A. (editor)
Gallos, P. (editor)
Publication year
2022
Abstract
We explored whether a multi-component approach - using a digital health device, the easypod™ auto-injector, the 'MySupport' patient support programme (PSP) and a Patient Activation Measure® (PAM®) - could improve adherence in patients receiving recombinant human growth hormone (r-hGH). A 13-item PAM was used to assess caregiver self-reported knowledge, resulting in two PAM scores for 88 patients at four UK hospitals after an average of 5.6 months. Most patients improved their PAM score by ≥1 level (43%) or maintained it (>-1 and
Subject
Auto-injector
Growth hormone
Patient activation measure
Patient support programme
To reference this document use:
http://resolver.tudelft.nl/uuid:ac953c9d-bd9b-4c16-9016-a6e0a62abb0b
DOI
https://doi.org/10.3233/shti220595
TNO identifier
962969
Publisher
IOS Press, Amsterdam
ISBN
9781643682853
Source
Studies in Health Technology and Informatics, 32nd Medical Informatics Europe Conference, Challenges of Trustable AI and Added-Value on Health, MIE 2022, 27 May 2022 through 30 May 2022, 294 (294), 817-818
Series
Studies in Health Technology and Informatics
Document type
bookPart